GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Kangtai Biological Products Co Ltd (SZSE:300601) » Definitions » Cyclically Adjusted Revenue per Share

Shenzhen Kangtai Biological Products Co (SZSE:300601) Cyclically Adjusted Revenue per Share : ¥2.06 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Shenzhen Kangtai Biological Products Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Shenzhen Kangtai Biological Products Co's adjusted revenue per share data for the fiscal year that ended in Dec. 2023 was ¥3.109. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥2.06 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-06), Shenzhen Kangtai Biological Products Co's current stock price is ¥ 17.45. Shenzhen Kangtai Biological Products Co's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec. 2023 was ¥2.06. Shenzhen Kangtai Biological Products Co's Cyclically Adjusted PS Ratio of today is 8.47.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Shenzhen Kangtai Biological Products Co was 41.33. The lowest was 8.86. And the median was 19.69.


Shenzhen Kangtai Biological Products Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Shenzhen Kangtai Biological Products Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Kangtai Biological Products Co Cyclically Adjusted Revenue per Share Chart

Shenzhen Kangtai Biological Products Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1.49 1.79 2.06

Shenzhen Kangtai Biological Products Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 2.06 -

Competitive Comparison of Shenzhen Kangtai Biological Products Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Kangtai Biological Products Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Kangtai Biological Products Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Kangtai Biological Products Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Shenzhen Kangtai Biological Products Co's Cyclically Adjusted PS Ratio falls into.



Shenzhen Kangtai Biological Products Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shenzhen Kangtai Biological Products Co's adjusted Revenue per Share data for the fiscal year that ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=3.109/114.7809*114.7809
=3.109

Current CPI (Dec. 2023) = 114.7809.

Shenzhen Kangtai Biological Products Co Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201412 0.366 99.000 0.424
201512 0.511 100.600 0.583
201612 0.615 102.600 0.688
201712 1.183 104.500 1.299
201812 2.025 106.500 2.182
201912 1.903 111.200 1.964
202012 2.102 111.500 2.164
202112 5.261 113.108 5.339
202212 2.855 115.116 2.847
202312 3.109 114.781 3.109

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Shenzhen Kangtai Biological Products Co  (SZSE:300601) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Shenzhen Kangtai Biological Products Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=17.45/2.06
=8.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Shenzhen Kangtai Biological Products Co was 41.33. The lowest was 8.86. And the median was 19.69.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Shenzhen Kangtai Biological Products Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Shenzhen Kangtai Biological Products Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Kangtai Biological Products Co (SZSE:300601) Business Description

Traded in Other Exchanges
N/A
Address
No. 6 Kefa Road, Science and Technology Industrial Park, Nanshan District, Shenzhen, CHN, 518057
Shenzhen Kangtai Biological Products Co Ltd is a human vaccine research and development company. The company is engaged in the research and development, production and sales of recombinant hepatitis B vaccine, b -type influenza Haemophilus conjugate vaccine, measles-rubella combined live attenuated vaccine, cell-free baibai broke b Haemophilus influenzae vaccine and other products.
Executives
Liu Jian Kai Directors, executives
Tao Jin Secretary Dong
Zheng Hai Fa Directors, executives
Zhou Hui Executives
Miao Xiang Directors, executives
Wen Fei Dong Director
Du Wei Min Directors, executives
Lv Zhi Yun Supervisors
Gan Jian Hui Executives
Zhu Zheng Yu Executives
Liu Qun Executives
Li Tong Executives
Yuan Li Ping Director
Li Xiang Ming Independent director

Shenzhen Kangtai Biological Products Co (SZSE:300601) Headlines

No Headlines